Mercury Conference Confronts Contentious Topics
News May 27, 2013
One of the panel sessions at the ‘Mercury 2013’ International Conference in Edinburgh (28th July - 2nd Aug) “will be highly contentious and should result in a heated debate,” says Prof. K. Clive Thompson who will be chairing the session with Eric Uram from SafeMinds.
Taking place on Tuesday 30th July at the Edinburgh International Conference Centre, the panel session will explore topical public concerns about mercury and health.
Experts in this field will discuss the toxicological significance of mercury exposure from dental amalgams, vaccines and fish consumption for vulnerable groups, and will debate whether current concerns are scientifically justified.
The continued use of thiomersal to preserve vaccines is the subject of much debate. It has been used for over 80 years and some passionately believe that it causes harm to the newly born (e.g. Autism) when used in certain vaccines, whilst others would dispute this.
The recent 32 deaths from the tragic fungal meningitis outbreak associated with compounded methylprednisolone acetate (MPA), a steroid injectable product, highlights a potential risk from not using a suitable preservative in vaccines (see www.fda.gov/NewsEvents/Testimony/ucm327664.htm)
The benefits of eating a diet high in oily fish will be weighed against the risk from ingesting elevated amounts of methyl mercury. A large number of comprehensive studies has been carried out and to-date there is no agreed consensus.
Finally, the panel will discuss whether mercury amalgam fillings cause harm. Alternative, tooth-colored materials are being used to replace mercury amalgam fillings. These vary in composition and properties, and include composites, cements, and sealants.
The panel will examine the degree of assessment that has been undertaken on these replacement fillings, and whether mercury fillings should be withdrawn.
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
This Seed Could Bring Clean Water to MillionsNews
Biomedical Engineering and Chemical Engineering Professors Bob Tilton and Todd Przybycien recently co-authored a paper with Ph.D. students Brittany Nordmark and Toni Bechtel, and alumnus John Riley, further refining a process that could soon help provide clean water to many in water-scarce regions. The process, created by Tilton’s former student and co-author Stephanie Velegol, uses sand and plant materials readily available in many developing nations to create a cheap and effective water filtration medium, termed “f-sand.”READ MORE
New Speakers from Roche and Imperial College London Announced for SMi’s ADMET EventNews
SMi Group Reports: With less than 4 weeks left until the 13th annual ADMET Conference commences in London, SMi announces two new speakers joining the event.READ MORE